Innovative digital solution to save more lives.
In this interactive session, we will discuss with a panel of experts the impact of the EVITA Platform on the healthcare system and Health Technology Assessment. This digital platform, developed by the EVITA – Hereditary Cancer Association, is designed to meet the needs of people and families affected by hereditary cancer syndromes, as well as doctors and researchers. Currently, there is a failure to identify 80% of carriers of genetic variants associated with this type of cancer, which accounts for around 10% of all cases. This condition appears at an early age, resulting in 7,000 new cases every year in Portugal and almost half a million in Europe.
Coordination:
Tamara Milagre